Ads

 

Ads

 

Ads

 

Nasdaq or NYSE related Biotechnology: In Vitro & In Vivo Diagnostic Substances industry Top Companies List by Market Cap as of January 2024

Nasdaq or NYSE listed Biotechnology: In Vitro & In Vivo Diagnostic Substances industry Top Companies List by Market Cap as of Jan-05-2024. Nasdaq and NYSE related Biotechnology: In Vitro & In Vivo Diagnostic Substances industry Largest Companies List by Market Cap as of Jan-05-2024

  1. IDEXX Laboratories

    World Rank (Jan-05-2024)
    393
    Market Cap (Jan-05-2024)
    44.723 Billion USD
    World Rank (Jul-30-2023)
    386
    Market Cap (Jul-30-2023)
    45.883 Billion USD
    World Rank (Dec-25-2022)
    498
    Market Cap (Dec-25-2022)
    34.003 Billion USD
    World Rank (Jan-07-2022)
    415
    Market Cap (Jan-07-2022)
    46.66 Billion USD
    Annual Revenue in USD
    3,367 Million USD
    Annual Operating Income in USD
    898 Million USD
    Annual Net Income in USD
    679 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile

    IDEXX Laboratories, Inc. is a leader in pet healthcare innovation, serving practicing veterinarians around the world. Headquarters is in USA.

    Idexx is animal healthcare company and they have over 7,000 employees across 175 countries.

    Idexx Laboratories engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets.

  2. Lantheus Holdings

    World Rank (Jan-05-2024)
    3,237
    Market Cap (Jan-05-2024)
    4.406 Billion USD
    World Rank (Jul-30-2023)
    2,522
    Market Cap (Jul-30-2023)
    6.010 Billion USD
    World Rank (Dec-25-2022)
    3,658
    Market Cap (Dec-25-2022)
    3.485 Billion USD
    World Rank (Jan-07-2022)
    6,662
    Market Cap (Jan-07-2022)
    1.82 Billion USD
    Annual Revenue in USD
    935 Million USD
    Annual Operating Income in USD
    36 Million USD
    Annual Net Income in USD
    28 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    Medical diagnosis and research oriented healthcare company with headquarters is in Massachusetts, USA.

  3. Neogen Corporation

    World Rank (Jan-05-2024)
    3,352
    Market Cap (Jan-05-2024)
    4.227 Billion USD
    World Rank (Jul-30-2023)
    2,981
    Market Cap (Jul-30-2023)
    4.993 Billion USD
    World Rank (Dec-25-2022)
    3,893
    Market Cap (Dec-25-2022)
    3.214 Billion USD
    World Rank (Jan-07-2022)
    3,668
    Market Cap (Jan-07-2022)
    4.31 Billion USD
    Annual Revenue in USD
    527 Million USD
    Annual Net Income in USD
    48 Million USD
    Annual Results for Period Ending
    May-2022 ending year
    Headquarters Country
    Company Profile

    Neogen Corporation is a Food Processing, Animal Protein and Agriculture Industries company. It serve the companion and performance animal industries as well as the fields of life sciences and toxicology. The headquarters is in USA.

  4. Intellia Therapeutics

    World Rank (Jan-05-2024)
    4,779
    Market Cap (Jan-05-2024)
    2.644 Billion USD
    World Rank (Jul-30-2023)
    3,722
    Market Cap (Jul-30-2023)
    3.734 Billion USD
    World Rank (Dec-25-2022)
    4,066
    Market Cap (Dec-25-2022)
    3.016 Billion USD
    World Rank (Jan-07-2022)
    2,284
    Market Cap (Jan-07-2022)
    7.87 Billion USD
    Annual Revenue in USD
    52 Million USD
    Annual Operating Income in USD
    -458 Million USD
    Annual Net Income in USD
    -474 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    Intellia Therapeutics is a Biotechnology company. The company annual revenue is 43.2 million USD, total assets is 334.2 million USD and 211 employees as on 2019. The headquarters is in USA.

  5. Celldex Therapeutics

    World Rank (Jan-05-2024)
    5,438
    Market Cap (Jan-05-2024)
    2.151 Billion USD
    World Rank (Jul-30-2023)
    6,490
    Market Cap (Jul-30-2023)
    1.640 Billion USD
    World Rank (Dec-25-2022)
    5,323
    Market Cap (Dec-25-2022)
    2.078 Billion USD
    World Rank (Jan-07-2022)
    6,911
    Market Cap (Jan-07-2022)
    1.71 Billion USD
    Annual Revenue in USD
    2 Million USD
    Annual Operating Income in USD
    -107 Million USD
    Annual Net Income in USD
    -112 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. Its pipeline includes immunotherapies and other targeted biologics derived from a broad set of complementary technologies which have the ability to engage the human immune system and/or directly inhibit tumors to treat specific types of cancer or other diseases. Headquarters is in USA.

  6. Myriad Genetics

    World Rank (Jan-05-2024)
    6,445
    Market Cap (Jan-05-2024)
    1.629 Billion USD
    World Rank (Jul-30-2023)
    6,072
    Market Cap (Jul-30-2023)
    1.829 Billion USD
    World Rank (Dec-25-2022)
    7,296
    Market Cap (Dec-25-2022)
    1.267 Billion USD
    World Rank (Jan-07-2022)
    6,296
    Market Cap (Jan-07-2022)
    1.99 Billion USD
    Annual Revenue in USD
    678 Million USD
    Annual Operating Income in USD
    -123 Million USD
    Annual Net Income in USD
    -112 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    Myriad Genetics is a Leading Molecular Diagnostic company. The headquarters is in USA.
  7. OPKO Health Inc.

    World Rank (Jan-05-2024)
    7,875
    Market Cap (Jan-05-2024)
    1.160 Billion USD
    World Rank (Jul-30-2023)
    7,067
    Market Cap (Jul-30-2023)
    1.437 Billion USD
    World Rank (Dec-25-2022)
    9,030
    Market Cap (Dec-25-2022)
    0.881 Billion USD
    World Rank (Jan-07-2022)
    4,822
    Market Cap (Jan-07-2022)
    3.03 Billion USD
    Annual Revenue in USD
    1,004 Million USD
    Annual Operating Income in USD
    -246 Million USD
    Annual Net Income in USD
    -328 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    OPKO Health is a Healthcare Company focused comprehensive diagnostics laboratories, robust research and development pipeline and unique pharmaceutical business solutions. The headquarters is in USA.
  8. LumiraDx Limited

    World Rank (Jan-05-2024)
    16,811
    Market Cap (Jan-05-2024)
    0.247 Billion USD
    World Rank (Jul-30-2023)
    17,990
    Market Cap (Jul-30-2023)
    0.202 Billion USD
    World Rank (Dec-25-2022)
    16,026
    Market Cap (Dec-25-2022)
    0.286 Billion USD
    Headquarters Country

Share

Ads